Dr Sarah Prinsloo PhD, M.A., LMFT-S, LPC, BCIA
Bringing the Latest Science to Cancer Survivors Today
Dr. Sarah Prinsloo, enjoyed a 15 year career as a faculty member and applied neuroscientist at The University of Texas MD Anderson Cancer Center, with appointments in both Palliative, Rehabilitation, and Integrative Medicine and the Department of Neurosurgery.
She holds degrees from the University of Houston and St. Mary's University and completed postdoctoral training in integrative oncology and biomedical imaging. Dr. Prinsloo is also a licensed marriage and family therapist with extensive teaching, research, and clinical experience.
Her research focuses on neuromodulation, pain and cancer-related symptom management, and she has published widely and received numerous honors and research grants. ​
Title: Understanding and preventing cortical changes related to chemotherapy-induced peripheral neuropathy
Funding Source: Rising Tide Foundation, MD Anderson Cancer Center IRG, 2024-2025, Principal Investigator
Title: Optimizing treatments for chemotherapy-induced peripheral neuropathy
Funding Source: American Cancer Society/Rising Tide Foundation, 2019 - 2025, Principal Investigator
​
Title: Registry study for Transcranial Magnetic Stimulation in brain tumor patients
Funding Source: Nexstim Corporation, 2021-2026, Principal Investigator
​
Title: A Combination therapy to treat cancer-related fatigue
Funding Source: NIH/NCI, 2018 - 2023, Co-Investigator
​
Title: Neuromodulation as a treatment for chemotherapy-induced peripheral neuropathy
Funding Source: National Center for Complementary and Integrative Health, 2014-2019, Principal Investigator
​​
Title: Biomarker identification and design of a neuromodulatory treatment program for the management of chronic neuropathic pain in cancer patients
Funding Source: American Cancer Society, Hille Foundation, 2011 - 2012, Principal Investigator